Home
Products
Learn
About
Pricing
Log In
Back
BMRN
Asset Logo

BioMarin Pharmaceutical Inc.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-11.00%
Annual Growth

5 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

BioMarin Pharmaceutical Inc. is a global biotechnology company engaged in the development of genetic discovery into medicines that make an impact on the life of each patient. The Company has eight commercial therapies and a clinical and preclinical pipeline. Its commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno-associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Its key clinical programs include Vosoritide, BMN 333, BMN 390, BMN 351, BMN 349, and INZ-701. Its late-stage enzyme replacement therapy, INZ-701, is being developed for the treatment of ENPP1 deficiency.

📈 Performance

Price History*

-58.98%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$57.50

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in BMRN

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

31 weeks

💵 Average investment amount

$1,038

Last time a customer invested in BMRN

442 days
BMRN investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in BMRN also invest in...

Intellia Therapeutics Inc.

NTLA

🙌 Performance (5Yr p.a)

-10.44%

📊 Share price

$10.74 USD
Find Out More

🙌 Performance (5Yr p.a)

27.35%

📊 Share price

$498.84 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-9.43%

📊 Share price

$54.03 USD

🙌 Performance (5Yr p.a)

19.51%

📊 Share price

$575.22 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

55.90%

📊 Share price

$234.80 USD

Want more shares? Try these...

📊 Share price

$23.81 USD

🙌 Performance (5Yr p.a)

-4.16%

📊 Share price

$25.70 USD
Compare
Add to watchlist